Latest Market Operations News

QPM Energy has taken a significant step forward by signing a key agreement with Powerlink Queensland to connect its 112MW Isaac Power Station to the grid, targeting energisation by mid-2027.

Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.

1414 Degrees updates on the administration of its joint venture partner Vast Solar Aurora, exploring acquisition options while progressing key renewable projects. The company also advances its October 2025 placement with shareholder-approved options now moving towards ASX quotation.

Origin Energy has announced it will keep the Eraring Power Station operational until April 2029, extending its life by nearly two years to bolster NSW’s energy security during the shift to renewables.

1414 Degrees secures critical approvals from AEMO and ElectraNet for its 140 MW Aurora Battery Energy Storage System, advancing the project toward grid connection and commercial operation in 2026.

AEMO forecasts a severe domestic gas shortage in Western Australia from 2028, spotlighting H3 Energy’s Warro gas field as a critical potential solution amid rising prices and technical hurdles.

VanEck Investments Limited has released an updated Product Disclosure Statement detailing seven Australian fixed income ETFs listed on the ASX, offering investors diversified exposure across government bonds, corporate debt, and subordinated securities.

Metcash Limited reported steady FY26 half-year results with modest revenue growth, strong cash flow, and resilience amid tobacco sales decline. The company’s digital B2B marketplace 'Sorted' is rapidly expanding, underpinning future growth prospects.

McPherson’s Limited has secured a new $16.2 million debt facility with HSBC, significantly downsizing from its previous $52.5 million arrangement as part of its ongoing business transformation.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Impact Minerals Limited has announced a 10, 1 consolidation of its securities, including ordinary shares, options, and performance rights, pending security holder approval. This restructuring aims to streamline the capital structure ahead of December trading.

MyEco Group reveals a strategic pivot towards expanding its MyEco branded products, achieving a 9% sales increase in FY25, and implementing a $2.5 million cost-saving operational restructure aimed at EBITDA breakeven in FY26.